A Cross-sectional Study on the Association of Peptidoglycan Fragments Derived From Gut Microbiota With Colorectal Cancer
NCT ID: NCT06379412
Last Updated: 2024-04-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
200 participants
OBSERVATIONAL
2023-07-01
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intestinal Flora Differences Between Colorectal Cancer Patients and Healthy Individuals
NCT06875648
A Multi-center Study on Human Microecology Assisted Diagnosis of Colorectal Cancer
NCT05998915
Gut Mucosal Microbiota is Associated With Colorectal Cancer Relapse
NCT03385213
Study of Gut Microbiome and Colorectal Tumors
NCT03297996
Gut Microbiome in Colorectal Cancer
NCT04054908
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Colorectal Cancer(CRC)
People who are diagnosed with CRC by colonoscopy and pathological biopsy
observational study, no intervention
observational study, no intervention
Colorectal adenoma(CRA)
People who are diagnosed with CRA by colonoscopy and pathological biopsy
observational study, no intervention
observational study, no intervention
Colorectal polyp(CRP)
People who are diagnosed with CRP by colonoscopy and pathological biopsy
observational study, no intervention
observational study, no intervention
Healthy
People who have no obvious abnormality in the whole colon
observational study, no intervention
observational study, no intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
observational study, no intervention
observational study, no intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* People who agree to participate in this study and are willing to sign informed consent.
Exclusion Criteria
* Received any of the following drug treatments within 1 month before sample collection: ① Drugs used for the treatment of colorectal diseases; ② Antibiotics; ③probiotics; ④ Laxatives.
* Patients with a family history of colorectal cancer.
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zhujiang Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
He Xiaolong, Professor
Role: STUDY_DIRECTOR
Southern Medical University, China
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Zhujiang Hospital of Southern Medical University
Guangzhou, Guangdong, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Zhujianghmy
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.